Evidence map›Paper›PMID 28262687›Full record

ArticleScientific reports2017

The syndrome of central hypothyroidism and macroorchidism: IGSF1 controls TRHR and FSHB expression by differential modulation of pituitary TGFβ and Activin pathways.

Marta García, Raquel Barrio, Montserrat García-Lavandeira, Angela R Garcia-Rendueles, Adela Escudero, Esther Díaz-Rodríguez, Darya Gorbenko Del Blanco, Ana Fernández, Yolanda B de Rijke, Elena Vallespín and 10 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed, 1 pooled it
4.1field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 1 synthesis or guideline pooled it, 45 citations in OpenAlex.

  1. Guideline
  2. Identification of a Novel Nonsense Mutation in theChildren (Basel, Switzerland) · 2025
    Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Hypothalamic hormone deficiency enables physiological anorexia.bioRxiv : the preprint server for biology · 2024
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Hypoprolactinemia as a Clue to Diagnosis of Mild Central Hypothyroidism due toJournal of clinical research in pediatric endocrinology · 2020
    Article
  16. Article
  17. Recent advances in research on isolated congenital central hypothyroidism.Clinical pediatric endocrinology : case reports and clinical investigations : official journal of the Japanese Society for Pediatric Endocrinology · 2019
    Article
  18. Article
  19. Review
  20. Two siblings with congenital central hypothyroidism caused by a novel mutation in theClinical pediatric endocrinology : case reports and clinical investigations : official journal of the Japanese Society for Pediatric Endocrinology · 2018
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 9 institutions in 4 countries.

Marta GarcíaThyroid Molecular Laboratory, Institute for Medical and Molecular Genetics (INGEMM), La Paz University Hospital, Autonomous University of Madrid, Madrid, Spain.
Raquel BarrioPediatric Endocrinology and Diabetes, Ramón y Cajal University Hospital, Madrid, Spain.
Montserrat García-LavandeiraCentro de Investigación en Medicina Molecular y Enfermedades Crónicas (CIMUS), University of Santiago de Compostela, Instituto de Investigación Sanitaria (IDIS), Santiago de Compostela, Spain.
Angela R Garcia-RenduelesCentro de Investigación en Medicina Molecular y Enfermedades Crónicas (CIMUS), University of Santiago de Compostela, Instituto de Investigación Sanitaria (IDIS), Santiago de Compostela, Spain.
Adela EscuderoThyroid Molecular Laboratory, Institute for Medical and Molecular Genetics (INGEMM), La Paz University Hospital, Autonomous University of Madrid, Madrid, Spain.
Esther Díaz-RodríguezCentro de Investigación en Medicina Molecular y Enfermedades Crónicas (CIMUS), University of Santiago de Compostela, Instituto de Investigación Sanitaria (IDIS), Santiago de Compostela, Spain.
Darya Gorbenko Del BlancoDepartment of Pediatrics, subdivision of Endocrinology, Erasmus Medical Center, Rotterdam, The Netherlands.
Ana FernándezThyroid Molecular Laboratory, Institute for Medical and Molecular Genetics (INGEMM), La Paz University Hospital, Autonomous University of Madrid, Madrid, Spain.
Yolanda B de RijkeDepartment of Clinical Chemistry, Erasmus Medical Center, Rotterdam, The Netherlands.
Elena VallespínFunctional and Structural Genomics, Institute for Medical and Molecular Genetics (INGEMM), La Paz University Hospital, Madrid, Spain.
Julián NevadoFunctional and Structural Genomics, Institute for Medical and Molecular Genetics (INGEMM), La Paz University Hospital, Madrid, Spain.
Pablo LapunzinaFunctional and Structural Genomics, Institute for Medical and Molecular Genetics (INGEMM), La Paz University Hospital, Madrid, Spain.
Vilborg MatreDepartment of Biosciences, University of Oslo, Oslo, Norway.
Patricia M HinkleDepartment of Pharmacology and Physiology, University of Rochester Medical Center Rochester, NY, USA.
Anita C S Hokken-KoelegaDepartment of Pediatrics, subdivision of Endocrinology, Erasmus Medical Center, Rotterdam, The Netherlands.
María P de MiguelCell Engineering Laboratory, La Paz Hospital Research Institute IdiPAZ, Madrid, Spain.
José Manuel Cameselle-TeijeiroDepartment of Anatomic Pathology, Medical Faculty, University of Santiago de Compostela, Clinical University Hospital, Santiago de Compostela, Spain.
Manuel NistalDepartment of Anatomy, Histology and Neuroscience, Autonomous University of Madrid, Madrid, Spain.
Clara V AlvarezCentro de Investigación en Medicina Molecular y Enfermedades Crónicas (CIMUS), University of Santiago de Compostela, Instituto de Investigación Sanitaria (IDIS), Santiago de Compostela, Spain.
José C MorenoThyroid Molecular Laboratory, Institute for Medical and Molecular Genetics (INGEMM), La Paz University Hospital, Autonomous University of Madrid, Madrid, Spain.
Hospital Universitario La Paz · ESInstituto de Investigación Sanitaria de Santiago · ESUniversidad Autónoma de Madrid · ESErasmus MC · NLHospital La Paz Institute for Health Research · ESInstituto Cajal · ESUniversidade de Santiago de Compostela · ESUniversity of Oslo · NOUniversity of Rochester Medical Center · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

IGSF1 (Immunoglobulin Superfamily 1) gene defects cause central hypothyroidism and macroorchidism. However, the pathogenic mechanisms of the disease remain unclear. Based on a patient with a full deletion of IGSF1 clinically followed from neonate to adulthood, we investigated a common pituitary origin for hypothyroidism and macroorchidism, and the role of IGSF1 as regulator of pituitary hormone secretion. The patient showed congenital central hypothyroidism with reduced TSH biopotency, over-secretion of FSH at neonatal minipuberty and macroorchidism from 3 years of age. His markedly elevated inhibin B was unable to inhibit FSH secretion, indicating a status of pituitary inhibin B resistance. We show here that IGSF1 is expressed both in thyrotropes and gonadotropes of the pituitary and in Leydig and germ cells in the testes, but at very low levels in Sertoli cells. Furthermore, IGSF1 stimulates transcription of the thyrotropin-releasing hormone receptor (TRHR) by negative modulation of the TGFβ1-Smad signaling pathway, and enhances the synthesis and biopotency of TSH, the hormone secreted by thyrotropes. By contrast, IGSF1 strongly down-regulates the activin-Smad pathway, leading to reduced expression of FSHB, the hormone secreted by gonadotropes. In conclusion, two relevant molecular mechanisms linked to central hypothyroidism and macroorchidism in IGSF1 deficiency are identified, revealing IGSF1 as an important regulator of TGFβ/Activin pathways in the pituitary.

Indexed as

ActivinsAnimalsDNA Mutational AnalysisFollicle Stimulating Hormone, beta SubunitFollow-Up StudiesGene DeletionHumansHypothyroidismImmunoglobulinsInfant, NewbornMaleMembrane ProteinsMicePituitary GlandPromoter Regions, GeneticRatsActivinsFollicle Stimulating Hormone, beta SubunitIGSF1 protein, humanImmunoglobulinsMembrane ProteinsReceptors, Thyrotropin-Releasing HormoneSmad ProteinsTransforming Growth Factor beta

Identifiers

PMID28262687
PMCPMC5338029
OpenAlexW2593576193

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.